Principal Investigator

Scott Lee
Dryden-Peterson
Awardee Organization

Brigham And Women'S Hospital
United States

Fiscal Year
2023
Activity Code
R01
Early Stage Investigator Grants (ESI)
Not Applicable
Project End Date

A multilevel intervention (Potlako+) to improve timely cancer detection and treatment initiation

The HIV pandemic has intensified the growing burden of cancer in low- and middle-income countries (LMICs), where nearly three-quarters of all cancer deaths occur. The majority of patients in LMICs have advanced cancer stage and limited opportunity for survival. Meaningful improvements in cancer mortality in LMICs will require prompt diagnosis and efficient linkage to care, however research identifying effective strategies has not been conducted. Botswana has key resources in place— free-of-charge medical care including comprehensive cancer care, accessible primary clinics, and an internationally-emulated ART program— yet large gaps in timely cancer care and thus provides a key opportunity to innovate strategies to detect cancer earlier and engage patients in care. The Potlako pilot trial (ORBIT phase IIa), evaluating an intervention targeting diagnostic and pre-treatment intervals in a single district (27 communities) in Botswana, has successfully increased the number of patients entering cancer care and number treated with curative intent compared to historical controls. As a next step, the Potlako+ trial— a community-randomized (26 geographically diverse rural communities, 1:1), pragmatic, ORBIT phase IIb, type 1 hybrid effectiveness-implementation trial— will assess a complex, theory-informed intervention to promote earlier clinic presentation with symptoms suggestive of cancer, enable efficient diagnosis, and facilitate prompt initiation of oncologic treatment. The Potlako+ trial targets high burden cancers accounting for 60% of cancer deaths (breast, cervix, anus, penis, vulva, and head and neck) which are typically curable with early detection of symptoms. We utilize cancer stage at time of treatment initiation, incidence of curative intent treatment, and the duration of Models of Pathways to Treatment intervals as primary effectiveness endpoints. Implementation will be evaluated using the RE-AIM framework. The project will achieve three aims: 1) Assess the effectiveness of cancer symptom awareness intervention with rural residents (persons living with HIV and HIV-uninfected) aged 30 years and older in decreasing time to presentation with moderate and high probability cancer syndromes, 2) Assess impact of a comprehensive cancer patient navigation platform on reducing time to diagnosis and initiation of cancer treatment (diagnostic and pre-treatment intervals), and 3) Evaluate whether the combined multilevel intervention improves early stage treatment and cumulative incidence of curative intent treatment. Understanding the impact and implementation of these interventions will inform strategies of care for LMIC populations at increasing risk of cancer death and contribute to developing models of primary care in resourceconstrained environments.

Publications

  • Ibrahim Khalil A, Mpunga T, Wei F, Baussano I, de Martel C, Bray F, Stelzle D, Dryden-Peterson S, Jaquet A, Horner MJ, Awolude OA, Trejo MJ, Mudini W, Soliman AS, Sengayi-Muchengeti M, Coghill AE, van Aardt MC, De Vuyst H, Hawes SE, Broutet N, Dalal S, Clifford GM. Age-specific burden of cervical cancer associated with HIV: A global analysis with a focus on sub-Saharan Africa. International journal of cancer. 2022 Mar 1;150(5):761-772. Epub 2021 Oct 19. PMID: 34626498
  • Rubin E, Dryden-Peterson SL, Hammond SP, Lennes I, Letourneau AR, Pathak P, Sonmez T, Ünver MU. A Novel Approach to Equitable Distribution of Scarce Therapeutics: Institutional Experience Implementing a Reserve System for Allocation of COVID-19 Monoclonal Antibodies. Chest. 2021 Dec;160(6):2324-2331. Epub 2021 Aug 6. PMID: 34371010
  • Dryden-Peterson S, Kim A, Kim AY, Caniglia EC, Lennes I, Patel R, Gainer L, Dutton L, Donahue E, Gandhi RT, Baden LR, Woolley AE. Nirmatrelvir plus ritonavir for early COVID-19 and hospitalization in a large US health system. medRxiv : the preprint server for health sciences. 2022 Jun 17. PMID: 35734084
  • Dryden-Peterson S, Kim A, Kim AY, Caniglia EC, Lennes IT, Patel R, Gainer L, Dutton L, Donahue E, Gandhi RT, Baden LR, Woolley AE. Nirmatrelvir Plus Ritonavir for Early COVID-19 in a Large U.S. Health System : A Population-Based Cohort Study. Annals of internal medicine. 2023 Jan;176(1):77-84. Epub 2022 Dec 13. PMID: 36508742
  • Dykstra M, Malone B, Lekuntwane O, Efstathiou J, Letsatsi V, Elmore S, Castro C, Tapela N, Dryden-Peterson S. Impact of Community-Based Clinical Breast Examinations in Botswana. JCO global oncology. 2021 Jan;7:17-26. PMID: 33405960
  • Woolley AE, Dryden-Peterson S, Kim A, Naz-McLean S, Kelly C, Laibinis HH, Bagnall J, Livny J, Ma P, Orzechowski M, Shoresh N, Gabriel S, Hung DT, Cosimi LA. At-home Testing and Risk Factors for Acquisition of SARS-CoV-2 Infection in a Major US Metropolitan Area. medRxiv : the preprint server for health sciences. 2022 Feb 3. PMID: 35132425
  • Chipidza FE, Kayembe MKA, Nkele I, Efstathiou JA, Chabner BA, Abramson J, Dryden-Peterson SL, Sohani AR. Accuracy of Pathologic Diagnosis in Patients With Lymphoma and Survival: A Prospective Analysis From Botswana. JCO global oncology. 2021 Sep;7:1620-1632. PMID: 34860565
  • Naz-McLean S, Kim A, Zimmer A, Laibinis H, Lapan J, Tyman P, Hung J, Kelly C, Nagireddy H, Narayanan-Pandit S, McCarthy M, Ratnaparkhi S, Rutherford H, Patel R, Dryden-Peterson S, Hung DT, Woolley AE, Cosimi LA. Feasibility and lessons learned on remote trial implementation from TestBoston, a fully remote, longitudinal, large-scale COVID-19 surveillance study. PloS one. 2022 Jun 3;17(6):e0269127. doi: 10.1371/journal.pone.0269127. eCollection 2022. PMID: 35657813
  • Makhema J, Wirth KE, Pretorius Holme M, Gaolathe T, Mmalane M, Kadima E, Chakalisa U, Bennett K, Leidner J, Manyake K, Mbikiwa AM, Simon SV, Letlhogile R, Mukokomani K, van Widenfelt E, Moyo S, Lebelonyane R, Alwano MG, Powis KM, Dryden-Peterson SL, Kgathi C, Novitsky V, Moore J, Bachanas P, Abrams W, Block L, El-Halabi S, Marukutira T, Mills LA, Sexton C, Raizes E, Gaseitsiwe S, Bussmann H, Okui L, John O, Shapiro RL, Pals S, Michael H, Roland M, DeGruttola V, Lei Q, Wang R, Tchetgen Tchetgen E, Essex M, Lockman S. Universal Testing, Expanded Treatment, and Incidence of HIV Infection in Botswana. The New England journal of medicine. 2019 Jul 18;381(3):230-242. PMID: 31314967
  • Moahi K, Ralefala T, Nkele I, Triedman S, Sohani A, Musimar Z, Efstathiou J, Armand P, Lockman S, Dryden-Peterson S. HIV and Hodgkin Lymphoma Survival: A Prospective Study in Botswana. JCO global oncology. 2022 Jan;8:e2100163. PMID: 35025689
  • Dryden-Peterson S, Kim A, Joyce MR, Johnson JA, Kim AY, Baden LR, Woolley AE. Bebtelovimab for High-Risk Outpatients With Early COVID-19 in a Large US Health System. Open forum infectious diseases. 2022 Oct 27;9(11):ofac565. doi: 10.1093/ofid/ofac565. eCollection 2022 Nov. PMID: 36438619
  • Iyer HS, Kohler RE, Ramogola-Masire D, Brown C, Molebatsi K, Grover S, Kablay I, Bvochora-Nsingo M, Efstathiou JA, Lockman S, Tapela N, Dryden-Peterson SL. Explaining disparities in oncology health systems delays and stage at diagnosis between men and women in Botswana: A cohort study. PloS one. 2019 Jun 6;14(6):e0218094. doi: 10.1371/journal.pone.0218094. eCollection 2019. PMID: 31170274
  • Chakalisa U, Wirth K, Bennett K, Kadima E, Manyake K, Gaolathe T, Bachanas P, Marukutira T, Lebelonyane R, Dryden-Peterson S, Butler L, Mmalane M, Makhema J, Roland ME, Pretorius-Holme M, Essex M, Lockman S, Powis KM. Self-reported risky sexual practices among adolescents and young adults in Botswana. Southern African journal of HIV medicine. 2019 Jun 26;20(1):899. doi: 10.4102/sajhivmed.v20i1.899. eCollection 2019. PMID: 31308965
  • Dryden-Peterson S, Velásquez GE, Stopka TJ, Davey S, Lockman S, Ojikutu BO. Disparities in SARS-CoV-2 Testing in Massachusetts During the COVID-19 Pandemic. JAMA network open. 2021 Feb 1;4(2):e2037067. PMID: 33560423
  • Molebatsi K, Iyer HS, Kohler RE, Gabegwe K, Nkele I, Rabasha B, Botebele K, Barak T, Balosang S, Tapela NM, Dryden-Peterson SL. Improving identification of symptomatic cancer at primary care clinics: A predictive modeling analysis in Botswana. International journal of cancer. 2022 Nov 15;151(10):1663-1673. Epub 2022 Jun 29. PMID: 35716138
  • Woolley AE, Dryden-Peterson S, Kim A, Naz-McLean S, Kelly C, Laibinis HH, Bagnall J, Livny J, Ma P, Orzechowski M, Gomez J, Shoresh N, Gabriel S, Hung DT, Cosimi LA. At-home Testing and Risk Factors for Acquisition of SARS-CoV-2 Infection in a Major US Metropolitan Area. Open forum infectious diseases. 2022 Oct 5;9(11):ofac505. doi: 10.1093/ofid/ofac505. eCollection 2022 Nov. PMID: 36381614
  • Lemp JM, De Neve JW, Bussmann H, Chen S, Manne-Goehler J, Theilmann M, Marcus ME, Ebert C, Probst C, Tsabedze-Sibanyoni L, Sturua L, Kibachio JM, Moghaddam SS, Martins JS, Houinato D, Houehanou C, Gurung MS, Gathecha G, Farzadfar F, Dryden-Peterson S, Davies JI, Atun R, Vollmer S, Bärnighausen T, Geldsetzer P. Lifetime Prevalence of Cervical Cancer Screening in 55 Low- and Middle-Income Countries. JAMA. 2020 Oct 20;324(15):1532-1542. PMID: 33079153
  • Benchimol-Elkaim B, Dryden-Peterson S, Miller DR, Koh HK, Geller AC. Oral Antiviral Therapy Utilization Among Adults with Recent COVID-19 in the United States. Journal of general internal medicine. 2023 May;38(7):1717-1721. Epub 2023 Feb 28. PMID: 36853557
  • Slaught C, Williams V, Grover S, Bigger E, Kayembe M, Chiyapo S, Jackson NJ, Dryden-Peterson S, Kovarik CL, Wanat KA. A retrospective review of patients with Kaposi's sarcoma in Botswana. International journal of dermatology. 2019 Jun;58(6):707-712. Epub 2018 Nov 21. PMID: 30460985
  • Bortz RH 3rd, Florez C, Laudermilch E, Wirchnianski AS, Lasso G, Malonis RJ, Georgiev GI, Vergnolle O, Herrera NG, Morano NC, Campbell ST, Orner EP, Mengotto A, Dieterle ME, Fels JM, Haslwanter D, Jangra RK, Celikgil A, Kimmel D, Lee JH, Mariano MC, Nakouzi A, Quiroz J, Rivera J, Szymczak WA, Tong K, Barnhill J, Forsell MNE, Ahlm C, Stein DT, Pirofski LA, Goldstein DY, Garforth SJ, Almo SC, Daily JP, Prystowsky MB, Faix JD, Fox AS, Weiss LM, Lai JR, Chandran K. Single-Dilution COVID-19 Antibody Test with Qualitative and Quantitative Readouts. mSphere. 2021 Apr 21;6. (2). PMID: 33883259
  • Wirth KE, Gaolathe T, Pretorius Holme M, Mmalane M, Kadima E, Chakalisa U, Manyake K, Matildah Mbikiwa A, Simon SV, Letlhogile R, Mukokomani K, van Widenfelt E, Moyo S, Bennett K, Leidner J, Powis KM, Lebelonyane R, Alwano MG, Jarvis J, Dryden-Peterson SL, Kgathi C, Moore J, Bachanas P, Raizes E, Abrams W, Block L, Sento B, Novitsky V, El-Halabi S, Marukutira T, Mills LA, Sexton C, Pals S, Shapiro RL, Wang R, Lei Q, DeGruttola V, Makhema J, Essex M, Lockman S, Tchetgen Tchetgen EJ. Population uptake of HIV testing, treatment, viral suppression, and male circumcision following a community-based intervention in Botswana (Ya Tsie/BCPP): a cluster-randomised trial. The lancet. HIV. 2020 Jun;7(6):e422-e433. PMID: 32504575

Clinical Trials

Study Name Clinical Trial ID
A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation NCT04141449